Cargando…
Screening for hepatitis D and PEG-Interferon over Tenofovir enhance general hepatitis control efforts in Brazil
BACKGROUND: Hepatitis D virus (HDV), which requires the presence of hepatitis B virus (HBV), is a deadly yet neglected disease that rapidly leads to liver cancer and disease-induced mortality. This co-dependence creates complex transmission dynamics that make it difficult to predict the efficacy of...
Autores principales: | Goyal, Ashish, Romero-Severson, Ethan Obie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128631/ https://www.ncbi.nlm.nih.gov/pubmed/30192887 http://dx.doi.org/10.1371/journal.pone.0203831 |
Ejemplares similares
-
Change in global transmission rates of COVID-19 through May 6 2020
por: Romero-Severson, Ethan Obie, et al.
Publicado: (2020) -
Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients
por: He, Jingjing, et al.
Publicado: (2023) -
Correction: Sensitivity of joint contagiousness and susceptibility-based dynamic optimal control strategies for HIV prevention
por: Bulla, Ingo, et al.
Publicado: (2019) -
Sensitivity of joint contagiousness and susceptibility-based dynamic optimal control strategies for HIV prevention
por: Bulla, Ingo, et al.
Publicado: (2018) -
Comparison of pegylated interferon monotherapy and de novo pegylated interferon plus tenofovir combination therapy in patients with chronic hepatitis B
por: Zheng, Caixia, et al.
Publicado: (2019)